Investors - Zafgen

Read about Zafgen, a capital efficient company bringing together leading experts in metabolic diseases to develop beloranib, a novel treatment for obesity.

OVERVIEW

The domain ir.zafgen.com currently has a traffic classification of zero (the smaller the more users). We have examined twenty pages within the site ir.zafgen.com and found seventeen websites referencing ir.zafgen.com. We have discovered two public communication sites linked to this website.
Pages Crawled
20
Links to this site
17
Social Links
2

IR.ZAFGEN.COM TRAFFIC

The domain ir.zafgen.com has seen variant quantities of traffic in the past the year.
Traffic for ir.zafgen.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.zafgen.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.zafgen.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO DOMAIN

Zafgen - Dedicated to the Treatment of Obesity

Unmet Needs in Prader-Willi Syndrome. Zafgen is a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders. Zafgen Reports Fourth Quarter and Full Year 2014 Financial Results. Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2014 Financial Results.

WHAT DOES IR.ZAFGEN.COM LOOK LIKE?

Desktop Screenshot of ir.zafgen.com Mobile Screenshot of ir.zafgen.com Tablet Screenshot of ir.zafgen.com

IR.ZAFGEN.COM SERVER

We discovered that the main root page on ir.zafgen.com took one hundred and sixty-eight milliseconds to download. We could not detect a SSL certificate, so our web crawlers consider ir.zafgen.com not secure.
Load time
0.168 secs
SSL
NOT SECURE
Internet Protocol
206.200.251.19

SERVER OS

We discovered that this website is implementing the Microsoft-IIS/6.0 operating system.

HTML TITLE

Investors - Zafgen

DESCRIPTION

Read about Zafgen, a capital efficient company bringing together leading experts in metabolic diseases to develop beloranib, a novel treatment for obesity.

PARSED CONTENT

The domain ir.zafgen.com had the following in the homepage, "Unmet Needs in Prader-Willi Syndrome." We observed that the website stated " Annual Reports and Proxy Materials." It also stated " Annual Reports and Proxy Materials. Zafgen is a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity. The companys lead product candidate is beloranib, a novel, first-in-class, twice-weekly subcutaneous injection being developed for the treatment of multiple indications, including obesity and hyperphagia, or insati." The header had Zafgen as the highest ranking keyword. This keyword was followed by Pharmaceutical, Boston, and Drug which isn't as urgent as Zafgen. The other words the site used was Discovery. Biology is also included but could not be seen by search crawlers.

ANALYZE MORE WEBSITES

kibaredfox Eddy - DeviantArt

Forgot Password or Username? Deviant for 3 Years. This is the place where you can personalize your profile! By moving, adding and personalizing widgets.

Zafin Banking Product Pricing Lifecycle Management PPLM

Banks should look beyond just infrastructure providers when doing due diligence for cloud computing. Read the July 2015 edition of Relationship Banker. CUSTOMER-CENTRIC PRODUCT AND PRICING PROPOSITIONS. Customer engagement with your bank.